APA (7th ed.) Citation

I, R. M., JL, B. C., JM, D., JC, L. A., C, V. D. R., JA, G. E., . . . RF, D. (2023). Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma. Vox sanguinis, 118(4), 296. https://doi.org/10.1111/vox.13406

Chicago Style (17th ed.) Citation

I, Romera Martínez, et al. "Pathogen Reduction with Methylene Blue Does Not Have an Impact on the Clinical Effectiveness of COVID-19 Convalescent Plasma." Vox Sanguinis 118, no. 4 (2023): 296. https://doi.org/10.1111/vox.13406.

MLA (9th ed.) Citation

I, Romera Martínez, et al. "Pathogen Reduction with Methylene Blue Does Not Have an Impact on the Clinical Effectiveness of COVID-19 Convalescent Plasma." Vox Sanguinis, vol. 118, no. 4, 2023, p. 296, https://doi.org/10.1111/vox.13406.